Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183M
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
90.5M
-
Shares change
-
+317K
-
Total reported value, excl. options
-
$1.47B
-
Value change
-
-$13.8M
-
Put/Call ratio
-
0.24
-
Number of buys
-
88
-
Number of sells
-
-80
-
Price
-
$16.21
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q1 2021
222 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q1 2021.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.5M shares
of 183M outstanding shares and own 49.39% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (12.6M shares), VANGUARD GROUP INC (8.49M shares), BlackRock Inc. (7.14M shares), BAKER BROS. ADVISORS LP (5.99M shares), WELLINGTON MANAGEMENT GROUP LLP (5.85M shares), ArrowMark Colorado Holdings LLC (5.63M shares), STATE STREET CORP (4.58M shares), Clearbridge Investments, LLC (3.44M shares), JPMORGAN CHASE & CO (3.27M shares), and UBS OCONNOR LLC (2.33M shares).
This table shows the top 187 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.